# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-y...
Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report opera...
IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical c...
IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares.
Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Lt...
IMC Germany's accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannab...
With Germany delivering accelerated growth after legalization, IMC is keeping all options open to maximize shareholder valueTOR...
IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($...
IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company" or "IMC"), a leading medical cannabis company with op...